MRNA

Moderna, Inc. Common Stock NASDAQ
$143.8
Open: $135.37 High: $139.165 Low: $132.8 Close: $138.88
Range: 2022-06-23 - 2022-06-24
Volume:1,238,041
Market: Closed
MRNA
Moderna, Inc. Common Stock 200 TECHNOLOGY SQUARE https://www.modernatx.com
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
  • CEO: Stéphane Bancel
  • Employees: 2,700
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
MRNA News
Latest news about the MRNA